News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Forest Laboratories, Inc. (FRX), Gedeon Richter Ltd. May Do Additional Phase II Cariprazine Trial; Drug Misses Overall Goal



8/30/2010 8:06:42 AM

Bloomberg -- Gedeon Richter Nyrt., Hungary’s largest drugmaker, said that the Phase II clinical trial of Cariprazine for bipolar depression produced no “statistically significant” result compared with placebo treatment.

Read at Reuters
Read at Bloomberg


comments powered by Disqus
Reuters
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES